Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...
Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...
Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.
HealthDay on MSN13d
Primary Prevention Aspirin Use Decreased After Recommendation ChangeFRIDAY, Jan. 24, 2025 (HealthDay News) -- Among older adults and adults with low atherosclerotic cardiovascular disease ...
The research team of Professor Sin Gon Kim and Professor Nam Hoon Kim of department of internal medicine (Endocrinology and Metabolism) of Korea ...
A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...
After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.
Some Asian, Black and Mexican American adults at low ASCVD risk continue taking baby aspirin, despite risk and clinical guidance. Similar observations were reported for those on Medicaid or ...
About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage company developing a new class of genetic medicines for cardiovascular disease with the potential to transform ...
Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback